CD274 and neoplasm: The immune-desert phenotype tumors rarely responded to anti-PD-1/PD-L1 therapy, while the immune-inflamed tumor type has abundant adaptive and innate immune cell infiltration, and it is predicted to have a significantly better ICI therapy response and good survival prognosis in tumors [48,49,50].